Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | 0.0046 | 0.9 |
mRNA | IU1 | CTRPv2 | pan-cancer | AAC | -0.0049 | 0.9 |
mRNA | COL-3 | CTRPv2 | pan-cancer | AAC | 0.0047 | 0.9 |
mRNA | BRD-K27188169:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0063 | 0.9 |
mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | -0.0035 | 0.9 |
mRNA | CIL56 | CTRPv2 | pan-cancer | AAC | -0.0053 | 0.9 |
mRNA | sotrastaurin | CTRPv2 | pan-cancer | AAC | -0.0047 | 0.9 |
mRNA | pitstop2 | CTRPv2 | pan-cancer | AAC | -0.0055 | 0.9 |
mRNA | bendamustine | CTRPv2 | pan-cancer | AAC | -0.0042 | 0.9 |
mRNA | BRD-K17060750 | CTRPv2 | pan-cancer | AAC | -0.0042 | 0.9 |